Literature DB >> 16628124

Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use.

Frank Musshoff1, Burkhard Madea.   

Abstract

Especially for cannabinoids, analytical procedures for the verification of recent use and generally for the assessment of the extent of drug abuse are of interest in clinical and forensic toxicology. For confirmation of abstinence, urine analysis seems to be a useful tool. Serial monitoring of THC-COOH to creatinine ratios can differentiate between recent drug use and residual THC-COOH excretion (THC-COOH/creatinine ratio > or = 0.5 compared with previous specimen ratio). For an assessment of the extent of cannabis use, the determination of free and bound THC-COOH and especially of THC and 11-OH-THC glucuronides are suggested as useful but need further confirmation. Blood analysis is preferred for the interpretation of acute effects after cannabis abuse. The cannabis influence factor (CIF) was demonstrated as a better tool to interpret the concentrations of THC and its metabolites in blood in forensic cases and therefore it was proposed to assume absolute driving inability because of cannabis intoxication from a CIF > or = 10. Additionally, a higher CIF is indicative of a recent cannabis abuse. Also discrimination between occasional use of cannabis and regular drug consumption is possible by analysis of THC-COOH in blood samples because of the long plasma half-life of THC-COOH and its accumulation in the blood of frequent cannabis consumers. In routine tests, blood samples have to be taken within a prescribed 8-day-period, and a THC-COOH concentration >75 ng/mL is assumed to be associated with regular consumption of cannabis products, whereas plasma THC-COOH concentrations <5 ng/mL are associated with occasional consumption. In contrast to other illicit drugs, hair analysis lacks the sensitivity to act as a detector for cannabinoids. THC and especially the main metabolite THC-COOH have a very low incorporation rate into hair and THC is not highly bound to melanin, resulting in much lower concentrations in hair compared with other drugs. Additionally, THC is present in cannabis smoke and also can be incorporated into the hair only by contamination. For the determination of the main metabolite THC-COOH in the picogram or femtogram per milligram range, which indicates an active consumption, special analytical procedures, such as GC/MS/MS techniques, are required.

Entities:  

Mesh:

Year:  2006        PMID: 16628124     DOI: 10.1097/01.ftd.0000197091.07807.22

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  46 in total

1.  Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods.

Authors:  Nikie Korver; Piotr J Quee; Heleen B M Boos; Claudia J P Simons; Lieuwe de Haan
Journal:  Int J Methods Psychiatr Res       Date:  2012-03-15       Impact factor: 4.035

2.  Prenatal and postnatal cocaine exposure predict teen cocaine use.

Authors:  Virginia Delaney-Black; Lisa M Chiodo; John H Hannigan; Mark K Greenwald; James Janisse; Grace Patterson; Marilyn A Huestis; Robert T Partridge; Joel Ager; Robert J Sokol
Journal:  Neurotoxicol Teratol       Date:  2010-07-06       Impact factor: 3.763

3.  Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users.

Authors:  John Lewis; Anna Molnar; David Allsop; Jan Copeland; Shanlin Fu
Journal:  Int J Legal Med       Date:  2015-08-02       Impact factor: 2.686

4.  Just say "I don't": lack of concordance between teen report and biological measures of drug use.

Authors:  Virginia Delaney-Black; Lisa M Chiodo; John H Hannigan; Mark K Greenwald; James Janisse; Grace Patterson; Marilyn A Huestis; Joel Ager; Robert J Sokol
Journal:  Pediatrics       Date:  2010-10-25       Impact factor: 7.124

5.  Ultra-high performance liquid chromatography tandem mass-spectrometry for simple and simultaneous quantification of cannabinoids.

Authors:  Rohitash Jamwal; Ariel R Topletz; Bharat Ramratnam; Fatemeh Akhlaghi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2017-02-06       Impact factor: 3.205

Review 6.  Risks associated with the non-medicinal use of cannabis.

Authors:  Eva Hoch; Udo Bonnet; Rainer Thomasius; Florian Ganzer; Ursula Havemann-Reinecke; Ulrich W Preuss
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

7.  Recent Self-Reported Cannabis Use Is Associated With the Biometrics of Delta-9-Tetrahydrocannabinol.

Authors:  Matthew J Smith; Eva C Alden; Amy A Herrold; Andrea Roberts; Dan Stern; Joseph Jones; Allan Barnes; Kailyn P O'Connor; Marilyn A Huestis; Hans C Breiter
Journal:  J Stud Alcohol Drugs       Date:  2018-05       Impact factor: 2.582

8.  AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder.

Authors:  Ruud van Winkel; Nico J M van Beveren; Claudia Simons
Journal:  Neuropsychopharmacology       Date:  2011-07-20       Impact factor: 7.853

9.  Toward a comprehensive model of ∆(9)-tetrahydrocannabinol pharmacokinetics using a population pharmacokinetics approach.

Authors:  Brett C Ginsburg
Journal:  Clin Pharmacokinet       Date:  2015-02       Impact factor: 6.447

10.  Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.

Authors:  Garry Milman; Allan J Barnes; Ross H Lowe; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2010-01-04       Impact factor: 4.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.